Why Past Rail Mergers Are a Poor Guide
The Union Pacific-Norfolk Southern deal should be evaluated by weighing its potential benefits.
Bardach’s Path to a Better World
Over the last half-century, Eugene Bardach gave regulators key tools for charting a path to a better outcomes.
Rebuilding the U.S. Regulatory System
Experts map out reforms for reforming the U.S. regulatory system in the coming years.
The Supreme Court’s 2025–2026 Regulatory Term
Scholars examine the Court’s most important regulatory decisions of this past term.
The Constitution Does Not Prohibit Environmental Justice
A changing equal protection landscape does not change the legality of environmental justice initiatives.
GLP-1 Compounding After Drug Shortages
Apothecary Pharma recalled 22 vials of compounded tirzepatide injections nationwide because of concerns about sterility, USA TODAY reported on October 19. The recall followed a Food and Drug Administration (FDA) warning letter identifying substantial deficiencies in the pharmacy’s sterile-drug production practices. This incident reflects broader concerns about the safety of compounded glucagon-like peptide-1 receptor agonists… Read More »
Week in Review
Judge rules firing of inferior officer unlawful, FTC orders companies to disclose use of personal data, and more…
A Health Care Desert for Mothers
Scholar argues that rural hospital mergers put mothers at risk and suggests policy reforms.
A Legislative Lifeline for Independent Regulatory Agencies?
Congress should require the President to replace agency heads after termination.
Calls for Change in the Regulation of Telehealth Medicine
Scholars propose reforms to improve virtual care and access.










